Seeking Alpha
21 Sept 2026, 16:19 UTC · 1h ago
Verdict
Headline leans bearish. We score ULBI +0.60 across three claims.
Score contradicts the headline.
Leans bearish
From its wording — no explicit rating
+0.60strongly bullish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 0 new · 3 priced in
Ultralife's Q2-2026 operating income and adjusted EBITDA showed significant year-over-year gains.
Priced inanalysis of Q2-2026 results
So whatHigher EBITDA suggests an expansion in the valuation multiple if growth persists into H2.
More positive than 76% of claims this week
Ultralife reported a $1.1 million tariff refund contributing to Q2 results.
Continue reading
5 related stories
More positive than 70% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Priced inanalysis of Q2-2026 results
So whatThis non-recurring gain artificially inflates the current quarter's EPS relative to organic growth.
More positive than 49% of claims this week
The company maintains a current ratio of 2.9 and a quick ratio of 1.11.
Priced inanalysis of Q2-2026 results
So whatA quick ratio above 1.0 indicates no immediate need for external financing in the next 12 months.
More positive than 40% of claims this week
Which stocks this story touches
More positive than 70% of ticker scores this week
The company maintains a Buy rating with improving profitability and significant year-over-year gains in operating income and EBITDA.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−1.2%
Price is moving against the score
$5.58 vs $5.65 close before publication (Sep 18) · not market-adjusted
ULBI chart →
